State Street Corp Pax Medica, Inc. Call Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
About PaxMedica, Inc.
- Ticker PXMD
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,779,500
- Market Cap $1.41M
- Description
- PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...